Tandem Diabetes Care (TNDM) shares fell Monday after analysts from Wells Fargo and Bernstein downgraded the stock.
Tandem shares were more down more than 4% in recent trading after falling as much as 5.8% earlier.
Wells Fargo downgraded the stock to equal weight from overweight and cut its price target to $22 from $38, and Bernstein to market perform from outperform.
Trading volume stood at over 1.8 million shares against a daily average of about 1.3 million.
Price: 21.12, Change: -1.02, Percent Change: -4.61